Skip to main content
logo
Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
95.30
-1.15 (-1.19%)
At close: Oct 29, 2025, 4:00 PM EDT
96.00
+0.70 (0.73%)
After-hours: Oct 29, 2025, 7:00 PM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Total Discovery & Analytical Solutions Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Total Diagnostics Revenue (Pre-Q3 2022)
1.43B1.50B
Log In
Log In
Log In
Upgrade
Revenue (Other)
1.39B1.25B
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.81B2.76B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022)
1.39B1.25B
Log In
Log In
Log In
Upgrade
Diagnostics Product Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Diagnostics Service Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Total Diagnostics Revenue (Pre-Q3 2022)
1.43B1.50B
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.81B2.76B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Total Diagnostics Revenue (Pre-Q3 2022)
1.43B1.50B
Log In
Log In
Log In
Upgrade
Total Product Revenue
-2.34B
Log In
Log In
Log In
Upgrade
Total Service Revenue
-416.82M
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.81B2.76B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 4

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Life Sciences Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Applied Markets Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.81B2.76B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Discovery & Analytical Solutions Operating Income (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Operating Income (Other)
363.64M346.74M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
363.64M346.74M
Log In
Log In
Log In
Upgrade

EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Discovery & Analytical Solutions Operating Income (Post-Q2 2022)
453.14M448.02M
Log In
Log In
Log In
Upgrade
Diagnostics Operating Income (Pre-Q3 2022)
351.23M373.19M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
363.64M346.74M
Log In
Log In
Log In
Upgrade

EBIT 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Diagnostics Operating Income (Pre-Q3 2022)
351.23M373.19M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
363.64M346.74M
Log In
Log In
Log In
Upgrade
Updated Oct 27, 2025. Data Source: Fiscal.ai.